InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

Revenues for H2 2023 were affected by damages caused by the terrorist attack on October 7, 2023 and the war in Gaza. However, InterCure it is entitled to full compensation from the Israeli...

Related Keywords

Ukraine ,Israel ,United States ,Gaza ,Israel General ,Australia ,United Kingdom ,Germany ,America ,Israeli ,Somekh Chaikin ,Alexander Rabinovitch ,Intercure Ltd ,Israel Defense ,Nasdaq ,Securities Exchange Commission On ,New Israeli Shekels ,Southern Israel Site ,Israel Defense Forces ,Israeli Governmental ,Southern Israel ,Intercure Noted ,Good Manufacturing Practices ,Annual Information Form ,Note Regarding Forward Looking ,Securities Exchange Commission ,Markets ,